Zobrazeno 1 - 10
of 107
pro vyhledávání: '"Philippe Backeljauw"'
Autor:
Constanze Lämmer, Philippe Backeljauw, Maite Tauber, Shankar Kanumakala, Sandro Loche, Karl Otfried Schwab, Roland Pfäffle, Charlotte Höybye, Elena Lundberg, Jovanna Dahlgren, Anna E. Ek, Tadej Battelino, Berit Kriström, Altaher Esmael, Markus Zabransky
Publikováno v:
Therapeutic Advances in Endocrinology and Metabolism, Vol 15 (2024)
Background: Recombinant human growth hormone (rhGH, somatropin) therapy is approved in children with Prader–Willi syndrome (PWS). Objectives: To report safety and effectiveness data for children with PWS treated with biosimilar rhGH (Omnitrope ® ,
Externí odkaz:
https://doaj.org/article/f04e838397bc42f1976fe16a970231a2
Autor:
Merlin G. Butler, Bradley S. Miller, Alicia Romano, Judith Ross, M. Jennifer Abuzzahab, Philippe Backeljauw, Vaneeta Bamba, Amrit Bhangoo, Nelly Mauras, Mitchell Geffner
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
Noonan, Turner, and Prader-Willi syndromes are classical genetic disorders that are marked by short stature. Each disorder has been recognized for several decades and is backed by extensive published literature describing its features, genetic origin
Externí odkaz:
https://doaj.org/article/be5ba1ffb43a4445bee8749412bcebc7
Autor:
Jan Wen, Christian Trolle, Mette H. Viuff, Steffen Ringgaard, Esben Laugesen, Ephraim J. Gutmark, Dhananjay Radhakrishnan Subramaniam, Philippe Backeljauw, Iris Gutmark-Little, Niels H. Andersen, Kristian H. Mortensen, Claus H. Gravholt
Publikováno v:
Journal of Cardiovascular Magnetic Resonance, Vol 20, Iss 1, Pp 1-12 (2018)
Abstract Background Women with Turner Syndrome have an increased risk for aortic dissection. Arterial stiffening is a risk factor for aortic dilatation and dissection. Here we investigate if arterial stiffening can be observed in Turner Syndrome pati
Externí odkaz:
https://doaj.org/article/0e2c68ffa6374d449a8d43a6ab19848b
Autor:
Philippe Backeljauw, Joanne C Blair, Jean-Marc Ferran, Nicky Kelepouris, Bradley S Miller, Alberto Pietropoli, Michel Polak, Lars Sävendahl, Franciska Verlinde, Tilman R Rohrer
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism.
Context Despite having normal growth hormone (GH) secretion, individuals with Turner syndrome (TS) have short stature. Treatment with recombinant human GH is recommended for TS girls with short stature. Objective This work aimed to evaluate the effec
Autor:
Tamara L. Wexler, Kent Reifschneider, Philippe Backeljauw, Javier F. Cárdenas, Andrew R. Hoffman, Bradley S. Miller, Kevin C. J. Yuen
Publikováno v:
Journal of Neurotrauma.
Autor:
Sarah Shim, Tara Streich-Tilles, Iris Gutmark-Little, Michael Yao, Jessica Shafer, Lesley Breech, Lori Casnellie, Philippe Backeljauw
Publikováno v:
Journal of Pediatric and Adolescent Gynecology.
Autor:
Judith Ross, Moshe Fridman, Nicky Kelepouris, Kristine Murray, Nils Krone, Michel Polak, Tilman R Rohrer, Alberto Pietropoli, Neil Lawrence, Philippe Backeljauw
Publikováno v:
Journal of the Endocrine Society. 7
Context Growth hormone (GH) therapy can increase linear growth in patients with growth hormone deficiency (GHD), Turner syndrome (TS), Noonan syndrome (NS), and Prader-Willi syndrome (PWS), although outcomes vary by disease state. Objective To assess
Autor:
Philippe Backeljauw, Shankar Kanumakala, Sandro Loche, Karl Otfried Schwab, Bradley S. Miller, Richard Levy, Kenneth McCormick, Hichem Zouater, Markus Zabransky, Kim Campbell
Publikováno v:
European Journal of Pediatrics. 181:2367-2378
There are known geographical differences in growth hormone deficiency (GHD) patient populations and treatment practices. Here, we present a comparison of safety and effectiveness data from patients treated with recombinant human growth hormone (rhGH)
Autor:
Gajanthan Muthuvel, Andrew Dauber, Eirene Alexandrou, Leah Tyzinski, Melissa Andrew, Vivian Hwa, Philippe Backeljauw
Publikováno v:
Hormone Research in Paediatrics.
Introduction: The metalloproteinase pregnancy-associated plasma protein A2 (PAPP-A2) cleaves insulin-like growth factor (IGF) binding proteins 3 and 5 to release bioactive IGF-I from its ternary complex. Patients with mutations in PAPP-A2 have growth
Autor:
Anders Juul, Philippe Backeljauw, Michael Højby, Masanobu Kawai, Rasmus Juul Kildemoes, Agnès Linglart, Nehama Zuckerman-Levin, Reiko Horikawa
Publikováno v:
Juul, A, Backeljauw, P, Højby, M, Kawai, M, Kildemoes, R J, Linglart, A, Zuckerman-Levin, N & Horikawa, R 2023, ' Somapacitan in children born small for gestational age : a multi-centre, open-label, controlled phase 2 study ', European Journal of Endocrinology, vol. 188, no. 1 . https://doi.org/10.1093/ejendo/lvac008
Objective Investigate efficacy, safety, and tolerability of 3 once-weekly somapacitan doses compared with daily growth hormone (GH) administration in short children born small for gestational age (SGA). Design Randomised, multi-centre, open-label, co